Telomeric impact of conventional chemotherapy (Q38155121)

29 August 2017

Telomeric impact of conventional chemotherapy (English)

1 reference

29 August 2017

1 reference

Yiming Lu

1

1 reference

29 August 2017

Waiian Leong

2

1 reference

29 August 2017

Olivier Guérin

3

1 reference

29 August 2017

Eric Gilson

4

1 reference

29 August 2017

Jing Ye

5

1 reference

29 August 2017

23 October 2013

1 reference

29 August 2017

Frontiers of medicine

1 reference

29 August 2017

7

1 reference

29 August 2017

4

1 reference

29 August 2017

411-417

1 reference

https://scigraph.springernature.com/pub.10.1007/s11684-013-0293-z

29 August 2017

0 references

cites work

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Immune parameters affecting the efficacy of chemotherapeutic regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

TRF2 and apollo cooperate with topoisomerase 2alpha to protect human telomeres from replicative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Platination of telomeric DNA by cisplatin disrupts recognition by TRF2 and TRF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Telomere dysfunction alters the chemotherapeutic profile of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Therapeutic doses of hydroxyurea cause telomere dysfunction and reduce TRF2 binding to telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

A telomere-dependent DNA damage checkpoint induced by prolonged mitotic arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Shelterin: the protein complex that shapes and safeguards human telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

The telosome/shelterin complex and its functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

The epigenetic regulation of mammalian telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Telomere position effect in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Human telomeric position effect is determined by chromosomal context and telomeric chromatin integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

CpG-island promoters drive transcription of human telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Mammalian telomeres end in a large duplex loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

A topological mechanism for TRF2-enhanced strand invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Telomerase modulates Wnt signalling by association with target gene chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

The human TTAGGG repeat factors 1 and 2 bind to a subset of interstitial telomeric sequences and satellite repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Human telomeric proteins occupy selective interstitial sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

The telomerase cycle: normal and pathological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Telomere dysfunction and evolution of intestinal carcinoma in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

How telomeres are replicated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Reverse transcriptase activity innate to DNA polymerase I and DNA topoisomerase I proteins of Streptomyces telomere complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Unexpected twist: harnessing the energy in positive supercoils to control telomere resolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

A non-canonical function of topoisomerase II in disentangling dysfunctional telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

DNA damage transiently increases TRF2 mRNA expression and telomerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

The telomeric protein TRF2 is critical for the protection of A549 cells from both telomere erosion and DNA double-strand breaks driven by salvicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Gemcitabine causes telomere attrition by stabilizing TRF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Telomere length shortening of peripheral blood mononuclear cells in solid-cancer patients undergoing standard-dose chemotherapy might be correlated with good treatment response and neutropenia severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

The aging effect of chemotherapy on cultured human mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Short telomeres limit tumor progression in vivo by inducing senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Cognitive impairments associated with breast cancer treatments: results from a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Nontelomeric TRF2-REST interaction modulates neuronal gene silencing and fate of tumor and stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0293-Z

Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.

21 January 2018

1 reference

12 December 2020

Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.

1 reference

12 December 2020

Long-term lymphoma survivors following high-dose chemotherapy and autograft: evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoir

1 reference

12 December 2020

Telomeric damage in early stage of chronic lymphocytic leukemia correlates with shelterin dysregulation

1 reference

12 December 2020

DNA Damage Persistence as Determinant of Tumor Sensitivity to the Combination of Topo I Inhibitors and Telomere-Targeting Agents

1 reference

12 December 2020

10.1007/S11684-013-0293-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

0 references

1 reference